UbiVac and Bristol Myers Squibb Team Up to Help Patients with Triple Negative Breast Cancer
Source: Pixabay

UbiVac and Bristol Myers Squibb Team Up to Help Patients with Triple Negative Breast Cancer

This week, UbiVac and Bristol Myers Squibb announced their clinical trial collaboration in a Biospace press release. The two companies, in a Phase 1b trial, look to study whether combining…

Continue Reading UbiVac and Bristol Myers Squibb Team Up to Help Patients with Triple Negative Breast Cancer
Genomic Markers Show the Risk of Progression for Smoldering Multiple Myeloma
mohamed_hassan / Pixabay

Genomic Markers Show the Risk of Progression for Smoldering Multiple Myeloma

According to the ASCO Post, researchers have discovered genomic characteristics of smoldering multiple myeloma that can tell one's risk of progression to multiple myeloma. Dr. Mark Bustoros and his team…

Continue Reading Genomic Markers Show the Risk of Progression for Smoldering Multiple Myeloma
New Data Gives Hope for a Limb-Girdle Muscular Dystrophy Gene Therapy
source: pixabay.com

New Data Gives Hope for a Limb-Girdle Muscular Dystrophy Gene Therapy

According to a story from BioPharma Dive, the drug company Sarepta Therapeutics is pushing forward with its plans to develop a gene therapy for limb-girdle muscular dystrophy (LGMD). The company…

Continue Reading New Data Gives Hope for a Limb-Girdle Muscular Dystrophy Gene Therapy

Myositis Research Could Aid in COVID-19 Vaccine Development

Myositis Myositis is an autoimmune disease that leads to muscle damage. Patients live with chronic disability due to the symptoms of this rare condition. These include skin rashes, pain, weakness, fatigue,…

Continue Reading Myositis Research Could Aid in COVID-19 Vaccine Development
Close Menu